Clinical Trial Update: Phase 3 Safety Study for the Treatment of Presbyopia Subjects [Phase 3]

View source ↗

Summary

LENZ Therapeutics reports the completion of a Phase 3 safety study assessing a treatment for presbyopia. The snippet does not provide trial results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• LENZ Therapeutics investigational product

Snippet

Sponsor: LENZ Therapeutics, Inc | Conditions: Presbyopia, Near Vision | Phase 3 | Status: COMPLETED